Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Syndax Pharmaceuticals (SNDX) Operating Margin: 2015-2020

Historic Operating Margin for Syndax Pharmaceuticals (SNDX) over the last 5 years, with Dec 2020 value amounting to -5,226.32%.

  • Syndax Pharmaceuticals' Operating Margin fell 148816.00% to -5,226.32% in Q4 2020 from the same period last year, while for Dec 2020 it was -4,708.17%, marking a year-over-year decrease of 91523.00%. This contributed to the annual value of -1,434.43% for FY2024, which is 11198923.00% down from last year.
  • As of Q4 2020, Syndax Pharmaceuticals' Operating Margin stood at -5,226.32%, which was up 0.23% from -5,238.26% recorded in Q3 2020.
  • In the past 5 years, Syndax Pharmaceuticals' Operating Margin ranged from a high of -1,633.61% in Q4 2017 and a low of -5,238.26% during Q3 2020.
  • Moreover, its 3-year median value for Operating Margin was -4,544.99% (2018), whereas its average is -4,500.82%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 201,917bps in 2017, then tumbled by 345,402bps in 2018.
  • Syndax Pharmaceuticals' Operating Margin (Quarterly) stood at -3,652.79% in 2016, then surged by 201,917bps to -1,633.61% in 2017, then crashed by 345,402bps to -5,087.63% in 2018, then spiked by 134,947bps to -3,738.16% in 2019, then slumped by 148,816bps to -5,226.32% in 2020.
  • Its Operating Margin was -5,226.32% in Q4 2020, compared to -5,238.26% in Q3 2020 and -4,382.59% in Q2 2020.